AIkido Pharma Inc. ( AIKI) Stock. Should you Buy or Sell? $ 5.88
0.02 (0.34 %)
AIkido Pharma Inc. Analysis
Updated on 10-09-2022| Symbol | AIKI |
| Price | $5.88 |
| Beta | 1.375 |
| Volume Avg. | $57.96 thousand |
| Market Cap | $30.85 M |
| 52 Week Range | $4.3 - $16.66 |
AIkido Pharma Inc. opened the day at $5.88 which is +'0.34 % on yesterday's close. AIkido Pharma Inc. has a 52 week high of $16.66 and 52 week low of $4.3, which is a difference of $12.36. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $30.85 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy AIkido Pharma Inc. for $30.85 M, it would take 15 years to get your money back. AIkido Pharma Inc. are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
AIkido Pharma Inc. Stock Forecast - Is AIkido Pharma Inc. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Neutral | |
| ROA Score | Neutral | |
| DE Score | Neutral | |
| PE Score | Sell | |
| PB Score | Neutral | |
| Overall Recommendation | Neutral |
Growth and Value
| PE Ratio | -2.949 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | 0.000 |
Valuing AIkido Pharma Inc.
| Price Book Value Ratio | 0.353 | Price To Book Ratio | 0.353 |
| Price To Sales Ratio | 0.000 | Price Earnings Ratio | -2.949 |
How liquid is AIkido Pharma Inc.
| Current Ratio | 74.262 |
| Quick Ratio | 68.967 |
Debt
| Debt Ratio | 0.009 | Debt Equity Ratio | 0.009 |
| Long Term Debt To Capitalization | 0.000 | Total Debt To Capitalization | 0.000 |
Latest news about AIkido Pharma Inc.
AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company. The post Why Is AIkido Pharma (AIKI) Stock Up 1,400%?
A 1 for 17 reverse stock split of AIkido Pharma, Inc. (NASDAQ: AIKI) has gone into effect. These are the details.
Which penny stocks are you watching right now? The post Trending Penny Stocks to Watch After Holiday Season appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
There are so many traders looking for the best penny stocks 2021… The post 5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
If you're making a penny stocks watchlist in November, here's three you should check out The post Best Penny Stocks to Buy Right Now? 3 to Watch This Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
About AIkido Pharma Inc.
Description :
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
